Fresenius Kabi Compounding recalls
FDA enforcement reports naming Fresenius Kabi Compounding, LLC as the recalling firm.
- Recall reports
- 15
- Class I (serious)
- 0
- Most recent report
- Feb 18, 2026
- Feb 18, 2026acyclovir sodium, 200 mg, 200mg added to 100 mL, 0Drug · Fresenius Kabi Compounding, LLCLack of Assurance of SterilityClass II
- Feb 18, 2026ketamine HCl, 1,000 mg, 1,000 mg per 100 mL (10 mg per mL) in Sodium Chloride Injection…Drug · Fresenius Kabi Compounding, LLCLack of Assurance of SterilityClass II
- Feb 18, 2026thiamine HCl, 500 mg, 500 mg added to 100 mL, 0Drug · Fresenius Kabi Compounding, LLCLack of Assurance of SterilityClass II
- Feb 18, 2026vancomycin HCl, 1Drug · Fresenius Kabi Compounding, LLCLack of Assurance of SterilityClass II
- Feb 18, 2026vancomycin HCl, 2 grams, 2 grams added to 500 mL, 0Drug · Fresenius Kabi Compounding, LLCLack of Assurance of SterilityClass II
- Oct 30, 2024NORepinephrine Bitartrate 0Drug · Fresenius Kabi Compounding, LLCcGMP violationsClass II
- Oct 30, 2024NORepinephrine Bitartrate 0Drug · Fresenius Kabi Compounding, LLCcGMP violationsClass II
- Oct 30, 2024Phenylephrine HCl 0Drug · Fresenius Kabi Compounding, LLCCGMP violationsClass II
- Oct 30, 2024EPINEPHrine 0Drug · Fresenius Kabi Compounding, LLCcGMP violationsClass II
- Oct 30, 2024Thiamine HCl 0Drug · Fresenius Kabi Compounding, LLCcGMP violationsClass II
- Oxytocin 0
- Phenylephrine HCl 0
- Phenylephrine HCl 0
- Phenylephrine HCl 0
- Vancomycin HCl 750 mg per 250 mL 0
Page 1 of 2